Skip to main content
BBramson-JParr-Elected-FIDSA
Brian Bramson and Jonathan Parr

Brian Bramson, MD, and Jonathan Parr, MD, MPH, have been named Fellows by the Infectious Diseases Society of America. Fellowship in IDSA is one of the highest honors in the field of infectious diseases, recognizing distinguished clinicians and scientists in the U.S. and around the world.

Dr. Bramson cares for people living with HIV, as well as multiple other acute and chronic infections at UNC Medical Center and at UNC’s Eastowne Clinic. He also teaches clinical reasoning and advanced physical diagnosis skills to medical students and residents in internal medicine, pediatrics, and family medicine.

Dr. Parr studies the molecular epidemiology of infectious disease, applying cutting-edge molecular and genomic tools to solve problems faced by marginalized populations across the globe. His work focuses on malaria in the Democratic Republic of the Congo, Ethiopia, and other sites, but he also conducts translational studies on viral hepatitis and syphilis. Dr. Parr is a founding member of the UNC Infectious Disease Epidemiology and Ecology Lab (IDEEL).

Both will be recognized during the FIDSA Induction Ceremony at the IDSA Business Meeting during IDWeek, October 19-22.

IDSA Fellows work across settings and disciplines, united by a shared purpose: to reduce the burdens of infectious diseases and build a healthier, more equitable future. Nominees are reviewed and elected by the IDSA Board of Directors. Fellows are approved by the IDSA Board of Directors for their sustained impact on research, education, public health and clinical care.

The Infectious Diseases Society of America is a global community of 13,000-plus clinicians, scientists and public health experts working together to solve humanity’s smallest and greatest challenges, from tiny microbes to global outbreaks. Rooted in science, committed to health equity and driven by curiosity, our compassionate and knowledgeable members safeguard the health of individuals, our communities and the world by advancing the treatment and prevention of infectious diseases.